MedVi vs Sprout Health: Pricing, speed, and compounded GLP-1s compared
MedVi vs Sprout Health is a cost, speed, and support comparison for telehealth GLP-1 options. Quick verdict: choose MedVi if you want a lower promotional first-month price and 24/7 certified medical support; choose Sprout Health if you prioritize lightning-quick approval and outcome-focused messaging.
Start MedVi for $179 first month
MedVi vs Sprout Health: how they differ at a glance
This comparison focuses on five key differences supported by source evidence: introductory pricing and ongoing cost, approval and onboarding speed, medication type and regulatory notes, support and care model, and outcome framing and reported results. Both providers operate online and may offer compounded semaglutide, but their positioning and specifics differ.
1. Introductory price and ongoing cost
MedVi advertises a winter promotional first month starting at $179 including fast, free shipping. MedVi’s ongoing standalone month is listed at $299, and a three-month plan is available at $649 (about $216/month). Sprout Health advertises $50 off the first month, bringing the initial cost to $199, with ongoing pricing at $249/month. All price statements are promotional or subject to the provider terms documented on their pages.
2. Approval, onboarding, and process speed
MedVi emphasizes a simple online intake with no clinic visits needed and a licensed clinician review after checkout; medication ships after review. Sprout Health emphasizes lightning-quick approval and fast-entry onboarding, framing itself for patients who want minimal friction to start therapy. Both operate as telehealth platforms and require clinician review to determine medical appropriateness.
3. Medication type and regulatory notes
Both sources note compounded semaglutide is offered. MedVi specifically states its semaglutide is compounded and that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Sprout Health includes a similar regulatory reminder that medication-specific approval status must be confirmed and that compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Neither provider claims compounded products are interchangeable with branded finished FDA-approved products.
4. Support, services, and care model
MedVi highlights 24/7 support from certified medical professionals and a no-clinic online process. MedVi states its program covers physician review, a personalized plan, 1:1 guidance, a metabolic report, and the medication shipped to your door. Sprout Health highlights a fast, safe, hassle-free delivery model and rapid prescription review, focusing on quick approval rather than continuous 24/7 support in the captured evidence.
5. Outcome framing and reported results
Sprout Health frames outcomes as losing 10 to 26 percent of body weight in 12 months, citing GLP-1 clinical outcome literature and noting individual results vary. MedVi presents self-reported patient data and states that MedVi patients typically result in 1 to 2 pounds per week weight loss after 4 weeks when following diet and exercise changes, while also cautioning results vary and that compounded medications are not FDA-approved.
Comparison table: MedVi vs Sprout Health
| Criteria | MedVi | Sprout Health |
|---|---|---|
| First-month price | $179 promo, fast free shipping stated | $199 after $50 off first month |
| Ongoing monthly price | $299 standalone; three-month at $649 (~$216/mo) | $249/month ongoing |
| Onboarding speed | Simple online intake, no clinic visits | Lightning-quick approval and fast entry |
| Medication type | Compounded semaglutide; not FDA-approved | Compounded options noted; approval status must be confirmed |
| Support | 24/7 certified medical support; personalized plan | Fast, hassle-free delivery; rapid prescription review |
| Outcome framing | Self-reported average 1-2 lbs/week after 4 weeks; results vary | Claims 10–26% body weight loss over 12 months; individual results vary |
What the evidence does not supply
The captured sources do not provide direct head-to-head outcome guarantees, independent trial results comparing the two, or detailed shipping and cancellation terms for Sprout Health. Any differences beyond the supplied pricing, support, approval speed, medication type, and outcome framing are not supplied and are not asserted here.
Final comparison and near-conclusion on MedVi vs Sprout Health
Both MedVi and Sprout Health are licensed telehealth GLP-1 platforms that provide online clinician review and deliver medication to your door. MedVi emphasizes a lower promotional first-month price, a no-clinic workflow, and 24/7 certified medical support. Sprout Health emphasizes fast approval, a $50 first-month discount, and an outcome-oriented message of 10 to 26 percent body weight change over 12 months. Both note that compounded medications are not FDA-approved and that prescriptions are subject to clinician review.
Get Sprout Health first-month offer
Learn Sprout Health approval timeline
Choose MedVi if…
You want the lowest advertised promotional first-month price in the captured evidence ($179), a fully no-clinic online process, and 24/7 certified medical support with a program that includes physician review and a personalized plan. MedVi also documents its patient-reported short-term weight outcomes and clarifies compounded medication regulatory status.
Choose Sprout Health if…
You prioritize lightning-quick approval and a fast-entry onboarding with an outcome-framed expectation of 10 to 26 percent body weight reduction over 12 months and want an initial $50-off promotional price that brings the first month to $199. Sprout Health is positioned for patients seeking minimal onboarding friction.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →More comparisons
